TRANSACTIONS
Versatility and adaptability in addressing unique challenges and opportunities
Acquisition of Independent Colleges Ltd.
YEAR: 2014
SECTOR: Education
TERMS: Not disclosed
Independent Colleges Ltd. ("Independent Colleges") is a leading provider of third level courses to students in Ireland. The company also operates one of the largest English language teaching facilities in Ireland under the International House brand.
Pegasus Capital advised members of the Barry family on an acquisition of the company. The transaction enabled the new owners to focus on growing the business and refining the course offering based on those courses that they believed would be most popular with students.
Management buy-in of Aalto Bio Reagents Ltd.
YEAR: 2014
SECTOR: Healthcare
TERMS: Not disclosed
Founded in 1978 by brothers Peter and Aidan O'Boyle, Aalto Bio Reagents Ltd. ("Aalto Bio Reagents") is a leading provider of raw materials to the in-vitro diagnostics industry and to research laboratories globally. The company is particularly focused on rare tropical diseases including the zika, chikungunya and dengue virus.
To facilitate the retirement of Aalto Bio Reagents' founders, Pegasus Capital identified a new management team and advised on a management buy-in transaction.
Sale of Cappella Peel Away Inc. to Stentys SA
YEAR: 2014
SECTOR: Healthcare
TERMS: Not disclosed
Cappella Medical Devices Ltd. is an Irish-based vascular medical device company. Its proprietary Peel Away sheath deployment system is used to deploy self-expanding stents with great accuracy.
Pegasus Capital advised the company on the sale of Cappella Peel Away Inc., which holds a global and perpetual licence to the Peel Away technology for coronary stent applications, to French-based Stentys SA, a medical device company listed on the Euronext stock exchange in Paris.
Fundraising for Embo Medical Ltd.
YEAR: 2014
SECTOR: Healthcare
TERMS: Not disclosed
Embo Medical Ltd. ("Embo Medical") is an early stage medical device spin-out company of the National University of Ireland, Galway. It is focused on developing technology to shut down blood flow in blood vessels.
In 2015, Pegasus Capital subsequently advised Embo Medical's founding shareholders on the USD 43.5 million sale of the company to CR Bard Inc.
Sale of GenCell BioSystems Ltd. to Becton, Dickinson & Company
YEAR: 2014
SECTOR: Healthcare
TERMS: EUR 135,000,000
GenCell BioSystems Ltd. ("GenCell BioSystems") is an innovative lifesciences technology company. Its CLiC system fully automates library preparation for next-generation DNA sequencing using proprietary composite liquid cell technology.
Pegasus Capital advised on the sale of the company to US-based Becton Dickinson & Co. a major global healthcare and lifesciences leader.
The sale will enable GenCell BioSystems to commercialise its technology on a global basis under the Becton Dickinson & Co. umbrella.
Sale of The Jelly Bean Factory to Cloetta AB
YEAR: 2014
SECTOR: Consumer & Food
TERMS: EUR 28,800,000
The Jelly Bean Factory is one of Ireland's leading confectionery businesses. The Jelly Bean Factory was established in 1998 by father and son team, Peter and Richard Cullen, and it produces in excess of 12 million gourmet jelly beans in 36 different flavours each day from its production facility in Dublin.
Pegasus Capital advised on the sale of an initial 75% of The Jelly Bean Factory to Swedish-based Cloetta AB in 2014 and the remaining 25% of the business in 2016.
Fundraising for CleverCards Ltd.
YEAR: 2013
SECTOR: Software & TMT
TERMS: Not disclosed
CleverCards is a leading global provider of personalised digital and printed greeting cards which can be delivered globally. The company also uses AI and leverages platforms such as Facebook to generate personalised gift ideas.
Pegasus Capital advised the company on a series A funding round to support future growth.
Fundraising for Feedhenry Ltd.
YEAR: 2013
SECTOR: Software & TMT
TERMS: Not disclosed
FeedHenry Ltd. ("Feedhenry") is a provider of a SaaS-based mobile enterprise application platform. It enables companies to develop mobile app's on a single platform which can then be accessed by all forms of mobile device i.e. device/operating system agnostic, whilst providing uniformity and consistency in terms of how these app's access the company's back-end IT systems.
Pegasus Capital advised the company on a series A funding round, led by Intel Capital and with participation from VMware, Kernel Capital and Enterprise Ireland.
Fundraising for Adforce.com
YEAR: 2013
SECTOR: Software & TMT
TERMS: Not disclosed
Adforce.com is a leading provider of mobile advertising services, working with companies, advertising agencies and networks, and online publishers. The company works with some large global brands in creating highly effective advertising campaigns that deliver a strong return on investment.
Pegasus Capital advised the company on a funding round which was led by a number of private investors.
Fundraising for GenCell BioSystems Ltd.
YEAR: 2013
SECTOR: Healthcare
TERMS: Not disclosed
GenCell BioSystems Ltd. ("GenCell") is an innovative lifesciences technology company. Its CLiC system fully automates library preparation for next-generation DNA sequencing using proprietary composite liquid cell technology.
Pegasus Capital advised on the company on a series A fundraising with private investors. The funds raised were used for research & development and to fully commercialise GenCell BioSystem's technology.
Sale of Ramada Hyde Park and Ramada Ealing to Westmont Hospitality Group
YEAR: 2012
SECTOR: Consumer & Food
TERMS: STG £75,000,000
Ramada Hyde Park and Ramada Ealing are two large London based hotels. Pegasus Capital advised on a sale of the hotels to Westmont Hospitality Group, who subsequently conducted a significant refurbishment and rebranded the hotels under the Hilton brand.
The transaction facilitated significant new investment in the hotels to enable them to achieve their full potential.